Data:
{
"symbol": "LGND",
"price": 301.52,
"marketCap": 6042780713,
"beta": 0.976,
"lastDividend": 0,
"range": "166.1-326.63",
"change": 2.48,
"changePercentage": 0.82932,
"volume": 303691,
"averageVolume": 315538,
"companyName": "Ligand Pharmaceuticals Incorporated",
"currency": "USD",
"cik": "0000886163",
"isin": "US53220K5048",
"cusip": "53220K504",
"exchangeFullName": "NASDAQ Global Market",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.ligand.com",
"description": "Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company\u2019s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.",
"ceo": "Todd C. Davis",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "47",
"phone": "858 550 7500",
"address": "555 Heritage Drive",
"city": "Jupiter",
"state": "FL",
"zip": "33458",
"image": "https://images.financialmodelingprep.com/symbol/LGND.png",
"ipoDate": "1992-11-18",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "LGND",
"name": "Ligand Pharmaceuticals Incorporated",
"price": 307.37,
"changePercentage": -0.9634,
"change": -2.99,
"volume": 2733.84313,
"dayLow": 307.37,
"dayHigh": 310.54,
"yearHigh": 326.63,
"yearLow": 175.56,
"marketCap": 6160020920,
"priceAvg50": 291.6124,
"priceAvg200": 239.9904,
"exchange": "NASDAQ",
"open": 310.52,
"previousClose": 310.36,
"timestamp": 1790775255,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-19",
"v": 287.6799,
"c": 290.71
},
{
"t": "2026-08-20",
"v": 287.2217,
"c": 287.39
},
{
"t": "2026-08-21",
"v": 287.4861,
"c": 286.29
},
{
"t": "2026-08-24",
"v": 282.243,
"c": 280.18
},
{
"t": "2026-08-25",
"v": 282.5786,
"c": 281.72
},
{
"t": "2026-08-26",
"v": 286.8134,
"c": 287.85
},
{
"t": "2026-08-27",
"v": 284.8793,
"c": 284.52
},
{
"t": "2026-08-28",
"v": 280.0851,
"c": 280.49
},
{
"t": "2026-08-31",
"v": 281.7467,
"c": 284.1
},
{
"t": "2026-09-01",
"v": 283.9958,
"c": 284.27
},
{
"t": "2026-09-02",
"v": 286.4019,
"c": 286.92
},
{
"t": "2026-09-03",
"v": 287.1496,
"c": 289.74
},
{
"t": "2026-09-04",
"v": 286.8441,
"c": 285.6
},
{
"t": "2026-09-08",
"v": 285.414,
"c": 288.83
},
{
"t": "2026-09-09",
"v": 288.4993,
"c": 288.05
},
{
"t": "2026-09-10",
"v": 288.9336,
"c": 289.25
},
{
"t": "2026-09-11",
"v": 285.5785,
"c": 284.47
},
{
"t": "2026-09-14",
"v": 282.8732,
"c": 280.65
},
{
"t": "2026-09-15",
"v": 274.5352,
"c": 276.98
},
{
"t": "2026-09-16",
"v": 274.8635,
"c": 275.2
},
{
"t": "2026-09-17",
"v": 283.0802,
"c": 284.7
},
{
"t": "2026-09-18",
"v": 283.3728,
"c": 283.49
},
{
"t": "2026-09-21",
"v": 288.9468,
"c": 290.07
},
{
"t": "2026-09-22",
"v": 296.2598,
"c": 298.5
},
{
"t": "2026-09-23",
"v": 299.1762,
"c": 298.41
},
{
"t": "2026-09-24",
"v": 299.3705,
"c": 299.04
},
{
"t": "2026-09-25",
"v": 301.4211,
"c": 301.52
},
{
"t": "2026-09-28",
"v": 310.327,
"c": 314.1
},
{
"t": "2026-09-29",
"v": 308.797,
"c": 310.36
},
{
"t": "2026-09-30",
"v": 309.3588,
"c": 306.98
}
],
"vwap_summary": {
"days": 30,
"days_above": 19,
"days_below": 11,
"pct_days_above": 63,
"position": "below",
"gap_pct": -0.77,
"streak_days": 1
}
}
Data:
{
"volume": 2733.84313,
"avgVolume": 315538,
"short_ratio": [
{
"symbol": "LGND",
"file_date": "2026-09-29",
"date": "20260929",
"short_volume": 192756,
"short_exempt_volume": 0,
"total_volume": 243760,
"short_volume_ratio": 0.7908,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 289.33,
"vah": 302.41,
"val": 279.24,
"profile": [
{
"price": 271.39,
"volume": 17378
},
{
"price": 272.14,
"volume": 20380
},
{
"price": 272.89,
"volume": 39816
},
{
"price": 273.63,
"volume": 18742
},
{
"price": 274.38,
"volume": 39345
},
{
"price": 275.13,
"volume": 95616
},
{
"price": 275.88,
"volume": 30300
},
{
"price": 276.62,
"volume": 34795
},
{
"price": 277.37,
"volume": 7035
},
{
"price": 278.12,
"volume": 5600
},
{
"price": 278.87,
"volume": 3546
},
{
"price": 279.61,
"volume": 16028
},
{
"price": 280.36,
"volume": 15937
},
{
"price": 281.11,
"volume": 64195
},
{
"price": 281.86,
"volume": 51768
},
{
"price": 282.6,
"volume": 23130
},
{
"price": 283.35,
"volume": 97230
},
{
"price": 284.1,
"volume": 72733
},
{
"price": 284.85,
"volume": 179072
},
{
"price": 285.59,
"volume": 136455
},
{
"price": 286.34,
"volume": 145810
},
{
"price": 287.09,
"volume": 134307
},
{
"price": 287.84,
"volume": 109013
},
{
"price": 288.58,
"volume": 129595
},
{
"price": 289.33,
"volume": 188256
},
{
"price": 290.08,
"volume": 77823
},
{
"price": 290.83,
"volume": 23912
},
{
"price": 291.57,
"volume": 22983
},
{
"price": 292.32,
"volume": 24138
},
{
"price": 293.07,
"volume": 9362
},
{
"price": 293.82,
"volume": 5291
},
{
"price": 294.56,
"volume": 3858
},
{
"price": 295.31,
"volume": 11355
},
{
"price": 296.06,
"volume": 11859
},
{
"price": 296.81,
"volume": 14970
},
{
"price": 297.55,
"volume": 22098
},
{
"price": 298.3,
"volume": 62993
},
{
"price": 299.05,
"volume": 118178
},
{
"price": 299.79,
"volume": 106627
},
{
"price": 300.54,
"volume": 61155
},
{
"price": 301.29,
"volume": 37945
},
{
"price": 302.04,
"volume": 48805
},
{
"price": 302.78,
"volume": 21484
},
{
"price": 303.53,
"volume": 4902
},
{
"price": 304.28,
"volume": 68856
},
{
"price": 305.03,
"volume": 50882
},
{
"price": 305.77,
"volume": 45676
},
{
"price": 306.52,
"volume": 21159
},
{
"price": 307.27,
"volume": 18136
},
{
"price": 308.02,
"volume": 25215
},
{
"price": 308.76,
"volume": 23374
},
{
"price": 309.51,
"volume": 73763
},
{
"price": 310.26,
"volume": 45936
},
{
"price": 311.01,
"volume": 52707
},
{
"price": 311.75,
"volume": 20920
},
{
"price": 312.5,
"volume": 18370
},
{
"price": 313.25,
"volume": 2879
},
{
"price": 314.0,
"volume": 52124
},
{
"price": 314.74,
"volume": 2222
},
{
"price": 315.49,
"volume": 2842
}
],
"sessions": 20
}
}
Data:
{
"symbol": "LGND",
"marketCap": 6219943692,
"enterpriseValueTTM": 6344694692,
"evToSalesTTM": 21.837444128559728,
"evToOperatingCashFlowTTM": 48.19621774040397,
"evToFreeCashFlowTTM": 48.29821255281087,
"evToEBITDATTM": 23.177728918941625,
"netDebtToEBITDATTM": 0.455726398310812,
"currentRatioTTM": 31.177593289969188,
"incomeQualityTTM": 0.6674931548524491,
"grahamNumberTTM": 103.27612654986251,
"grahamNetNetTTM": 9.817674325873499,
"taxBurdenTTM": 0.8287877896470865,
"interestBurdenTTM": 0.9927119966292463,
"workingCapitalTTM": 1410380000,
"investedCapitalTTM": 1727605000,
"returnOnAssetsTTM": 0.09022473837708012,
"operatingReturnOnAssetsTTM": 0.054292922500927925,
"returnOnTangibleAssetsTTM": 0.1051789514103323,
"returnOnEquityTTM": 0.20061944636377255,
"returnOnInvestedCapitalTTM": 0.03908453921771651,
"returnOnCapitalEmployedTTM": 0.04718253465529823,
"earningsYieldTTM": 0.031673010015872353,
"freeCashFlowYieldTTM": 0.021119966113030852,
"capexToOperatingCashFlowTTM": 0.002111771989395562,
"capexToDepreciationTTM": 0.008446253873731543,
"capexToRevenueTTM": 0.0009568324028883948,
"salesGeneralAndAdministrativeToRevenueTTM": 0.3559967233652966,
"researchAndDevelopementToRevenueTTM": 0.14230644794900565,
"stockBasedCompensationToRevenueTTM": 0.18332977676205162,
"intangiblesToTotalAssetsTTM": 0.14217876136558585,
"averageReceivablesTTM": 62360000,
"averagePayablesTTM": 7334500,
"averageInventoryTTM": 11764500,
"daysOfSalesOutstandingTTM": 87.84110386794336,
"daysOfPayablesOutstandingTTM": 833.1088460138333,
"daysOfInventoryOutstandingTTM": 909.1117582817619,
"operatingCycleTTM": 996.9528621497053,
"cashConversionCycleTTM": 163.84401613587204,
"freeCashFlowToEquityTTM": 950865000,
"freeCashFlowToFirmTTM": 133855196.41791546,
"tangibleAssetValueTTM": 656731000,
"netCurrentAssetValueTTM": 238757000,
"grossProfitMarginTTM": 0.985817885193879,
"ebitMarginTTM": 0.8250407858416339,
"ebitdaMarginTTM": 0.9421735928024175,
"operatingProfitMarginTTM": 0.347385231739301,
"pretaxProfitMarginTTM": 0.8190278858134108,
"continuousOperationsProfitMarginTTM": 0.6788003111426231,
"netProfitMarginTTM": 0.6788003111426231,
"bottomLineProfitMarginTTM": 0.6788003111426231,
"receivablesTurnoverTTM": 4.155230113555104,
"payablesTurnoverTTM": 0.43811802232854863,
"inventoryTurnoverTTM": 0.40149079216603334,
"fixedAssetTurnoverTTM": 45.11521739130435,
"assetTurnoverTTM": 0.13291793904043003,
"quickRatioTTM": 30.95799811708319,
"solvencyRatioTTM": 0.18980612446741887,
"cashRatioTTM": 21.54018315645327,
"priceToEarningsRatioTTM": 31.004995004995006,
"priceToEarningsGrowthRatioTTM": 0.031364618688407564,
"forwardPriceToEarningsGrowthRatioTTM": 1.3616488148058614,
"priceToEarningsDilutedRatioTTM": 33.193582887700536,
"priceToEarningsDilutedGrowthRatioTTM": 0.03200517805753285,
"priceToBookRatioTTM": 6.435813650626967,
"priceToSalesRatioTTM": 21.408070750528324,
"priceToFreeCashFlowRatioTTM": 47.348560819091844,
"priceToOperatingCashFlowRatioTTM": 47.30029458459622,
"debtToAssetsRatioTTM": 0.5176201749871333,
"debtToEquityRatioTTM": 1.1694411255214383,
"debtToCapitalRatioTTM": 0.5390517916176942,
"longTermDebtToCapitalRatioTTM": 0.5379822454407839,
"financialLeverageRatioTTM": 2.2592649630600423,
"workingCapitalTurnoverRatioTTM": 0.2599779520456994,
"operatingCashFlowRatioTTM": 2.8167365628209518,
"operatingCashFlowSalesRatioTTM": 0.4530945611994135,
"freeCashFlowOperatingCashFlowRatioTTM": 0.9978882280106044,
"debtServiceCoverageRatioTTM": 37.64119547657512,
"interestCoverageRatioTTM": 16.305331179321485,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": 0.11634862429106645,
"capitalExpenditureCoverageRatioTTM": 473.5359712230216,
"dividendPaidAndCapexCoverageRatioTTM": 473.5359712230216,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 14.481483327518317,
"netIncomePerShareTTM": 9.830035388526143,
"interestDebtPerShareTTM": 56.70353386831481,
"cashPerShareTTM": 67.67472461745501,
"bookValuePerShareTTM": 48.22389473159547,
"tangibleBookValuePerShareTTM": 32.73343966505507,
"shareholdersEquityPerShareTTM": 48.22389473159547,
"operatingCashFlowPerShareTTM": 6.561481333798534,
"capexPerShareTTM": 0.013856352489657579,
"freeCashFlowPerShareTTM": 6.547624981308877,
"netIncomePerEBTTTM": 0.8287877896470865,
"ebtPerEbitTTM": 2.357693450906569,
"priceToFairValueTTM": 6.435813650626967,
"debtToMarketCapTTM": 0.1811260769850712,
"effectiveTaxRateTTM": 0.17121221035291348,
"enterpriseValueMultipleTTM": 23.177728918941625,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 268087000
}
],
"dcf": {
"symbol": "LGND",
"date": "2026-09-29",
"dcf": 38.57986628838593,
"Stock Price": 305.26
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "LGND",
"reportedCurrency": "USD",
"cik": "0000886163",
"filingDate": "2026-02-27",
"acceptedDate": "2026-02-27 16:02:23",
"fiscalYear": "2025",
"period": "FY",
"revenue": 268087000,
"costOfRevenue": 6587500,
"grossProfit": 261499500,
"researchAndDevelopmentExpenses": 81182000,
"generalAndAdministrativeExpenses": 92449000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 92449000,
"otherExpenses": 40669500,
"operatingExpenses": 214300500,
"costAndExpenses": 220888000,
"netInterestIncome": 8944000,
"interestIncome": 13659000,
"interestExpense": 4715000,
"depreciationAndAmortization": 33775000,
"ebitda": 192735000,
"ebit": 158960000,
"nonOperatingIncomeExcludingInterest": -111761000,
"operatingIncome": 47199000,
"totalOtherIncomeExpensesNet": 111761000,
"incomeBeforeTax": 158960000,
"incomeTaxExpense": 34507000,
"netIncomeFromContinuingOperations": 124453000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 124453000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 124453000,
"eps": 6.44,
"epsDiluted": 6.13,
"weightedAverageShsOut": 19338000,
"weightedAverageShsOutDil": 20294000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "LGND",
"reportedCurrency": "USD",
"cik": "0000886163",
"filingDate": "2026-02-27",
"acceptedDate": "2026-02-27 16:02:23",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 174927000,
"shortTermInvestments": 558594000,
"cashAndShortTermInvestments": 733521000,
"netReceivables": 61047000,
"accountsReceivables": 59601000,
"otherReceivables": 1446000,
"inventory": 9126000,
"prepaids": 0,
"otherCurrentAssets": 28577000,
"totalCurrentAssets": 832271000,
"propertyPlantEquipmentNet": 10794000,
"goodwill": 101541000,
"intangibleAssets": 422315000,
"goodwillAndIntangibleAssets": 523856000,
"longTermInvestments": 183583000,
"taxAssets": 8345000,
"otherNonCurrentAssets": 1788000,
"totalNonCurrentAssets": 728366000,
"otherAssets": 0,
"totalAssets": 1560637000,
"totalPayables": 6230000,
"accountPayables": 3238000,
"otherPayables": 2992000,
"accruedExpenses": 22691000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 1095000,
"taxPayables": 1239000,
"deferredRevenue": 621000,
"otherCurrentLiabilities": 6810000,
"totalCurrentLiabilities": 37447000,
"longTermDebt": 446192000,
"capitalLeaseObligationsNonCurrent": 4204000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 52607000,
"otherNonCurrentLiabilities": 2974999,
"totalNonCurrentLiabilities": 505977999,
"otherLiabilities": 0,
"capitalLeaseObligations": 5299000,
"totalLiabilities": 543425000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 20000,
"retainedEarnings": 608088000,
"additionalPaidInCapital": 400649000,
"accumulatedOtherComprehensiveIncomeLoss": 8455000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 1017212000,
"totalEquity": 1017212000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 1560637000,
"totalInvestments": 742177000,
"totalDebt": 451491000,
"netDebt": 276564000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "LGND",
"reportedCurrency": "USD",
"cik": "0000886163",
"filingDate": "2026-02-27",
"acceptedDate": "2026-02-27 16:02:23",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 124453000,
"depreciationAndAmortization": 35717000,
"deferredIncomeTax": 22684000,
"stockBasedCompensation": 0,
"changeInWorkingCapital": -12665000,
"accountsReceivables": -21737000,
"inventory": 4988000,
"accountsPayables": 5882000,
"otherWorkingCapital": -1798000,
"otherNonCashItems": -120830000,
"netCashProvidedByOperatingActivities": 49359000,
"investmentsInPropertyPlantAndEquipment": -11314000,
"acquisitionsNet": -8085000,
"purchasesOfInvestments": -730863000,
"salesMaturitiesOfInvestments": 377284000,
"otherInvestingActivities": -4344000,
"netCashProvidedByInvestingActivities": -377322000,
"netDebtIssuance": 338105000,
"longTermNetDebtIssuance": 338105000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 99891000,
"netCommonStockIssuance": 99891000,
"commonStockIssuance": 114891000,
"commonStockRepurchased": -15000000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -9773000,
"netCashProvidedByFinancingActivities": 428223000,
"effectOfForexChangesOnCash": 2360000,
"netChangeInCash": 102620000,
"cashAtEndOfPeriod": 174927000,
"cashAtBeginningOfPeriod": 72307000,
"operatingCashFlow": 49359000,
"capitalExpenditure": -452000,
"freeCashFlow": 48907000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 307.37,
"rsi": 62.773510322361595,
"sma20": 291.66249999999985,
"sma50": 291.65040000000016,
"sma200": 240.6116000000002,
"adx": 19.39970624345213,
"atr": 9.13,
"atr_pct": 2.97,
"atr_expansion_pct": 11.9,
"di_plus": 30.7,
"di_minus": 12.1,
"high_52w": 322.61,
"low_52w": 166.51,
"structure": {
"ema8": 302.52247542013606,
"ema21": 295.0115451579178,
"ema50": 289.6021456414211,
"ema200": 247.71342502122496,
"ema10": 300.6253560210745,
"ema20": 295.3011933257931,
"ema10_slope_pct": 4.03,
"ema20_slope_pct": 2.63,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 4.2,
"_no_bars": false,
"macd": {
"macd": 5.178,
"signal": 2.21,
"histogram": 2.968
},
"bollinger": {
"mid": 291.66,
"upper": 312.69,
"lower": 270.63,
"width_pct": 14.42
},
"crossover": {
"fresh_cross": true,
"pre_compressed": true,
"held_above_21": true,
"candles_since": 6,
"intraday_support": false
},
"momentum": {
"roc10": 11.7,
"ret_3d": 1.94,
"ret_5d": 3.0,
"roc10_accel": 8.09,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.01,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 0.86,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 95141017.75999999
},
"options": {
"checks": {
"call_vol_2x": true,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 3.1,
"iv_rank": 26.0
}
}
}
}
Data:
{
"prior_day": {
"high": 310.52,
"low": 306.98,
"close": 306.98,
"date": "2026-09-30"
},
"woodie_pivots": {
"PP": 307.87,
"R1": 308.75,
"S1": 305.21,
"R2": 311.4,
"S2": 304.33
},
"swing": {
"high_20d": 317.1,
"low_20d": 270.77,
"high_60d": 326.63,
"low_60d": 270.77
},
"orb": {
"high": 310.52,
"low": 306.98,
"date": "2026-09-30"
},
"vwap": 309.43,
"volume_profile": {
"poc": 289.33,
"vah": 302.41,
"val": 279.24,
"sessions": 20
},
"intraday": {
"h1_trend": "flat",
"h1_last": 306.98,
"h1_ema9": 307.48,
"h1_ema21": 305.65,
"m15_trend": "flat",
"m15_last": 306.98,
"m15_ema9": 308.46,
"m15_ema21": 308.05,
"rvol_intraday": 0.48,
"as_of_et": "2026-09-30 09:30"
},
"premarket": {
"date": "2026-09-29",
"high": 314.5,
"low": 311.64,
"last": 314.21,
"volume": 2503,
"gap_pct": 0.04,
"path": "08:40 311.64 -> 08:55 314.21",
"bars": 2,
"last_bar_et": "08:55"
},
"recent_daily": [
{
"d": "2026-08-26",
"o": 281.72,
"h": 289.66,
"l": 277.0074,
"c": 287.85,
"v": 147463.170975
},
{
"d": "2026-08-27",
"o": 284.71,
"h": 289.2,
"l": 282.3975,
"c": 284.52,
"v": 206326.239284
},
{
"d": "2026-08-28",
"o": 283.7,
"h": 283.995,
"l": 277.36,
"c": 280.49,
"v": 127696.027874
},
{
"d": "2026-08-31",
"o": 276.77,
"h": 285.9,
"l": 275.6,
"c": 284.1,
"v": 203701.528455
},
{
"d": "2026-09-01",
"o": 286.28,
"h": 290.4063,
"l": 281.99,
"c": 284.27,
"v": 185017.03556
},
{
"d": "2026-09-02",
"o": 285.73,
"h": 290.33,
"l": 281.69,
"c": 286.92,
"v": 189615.449385
},
{
"d": "2026-09-03",
"o": 286.92,
"h": 290.085,
"l": 281.88,
"c": 289.74,
"v": 190728.932114
},
{
"d": "2026-09-04",
"o": 287.41,
"h": 290,
"l": 285.47,
"c": 285.6,
"v": 132389.367915
},
{
"d": "2026-09-08",
"o": 285.05,
"h": 289.28,
"l": 278.3953,
"c": 288.83,
"v": 216423.06778
},
{
"d": "2026-09-09",
"o": 288.03,
"h": 291.82,
"l": 285.48,
"c": 288.05,
"v": 309964.425641
},
{
"d": "2026-09-10",
"o": 285,
"h": 291.26,
"l": 283.04,
"c": 289.25,
"v": 146553.468814
},
{
"d": "2026-09-11",
"o": 291.48,
"h": 294,
"l": 283.77,
"c": 284.47,
"v": 261166.830286
},
{
"d": "2026-09-14",
"o": 284.93,
"h": 287.14,
"l": 280.12,
"c": 280.65,
"v": 158774.507575
},
{
"d": "2026-09-15",
"o": 280.53,
"h": 280.53,
"l": 270.77,
"c": 276.98,
"v": 180228.110616
},
{
"d": "2026-09-16",
"o": 277.97,
"h": 278.74,
"l": 271.215,
"c": 275.2,
"v": 299044.921485
},
{
"d": "2026-09-17",
"o": 279.51,
"h": 285.51,
"l": 273.102,
"c": 284.7,
"v": 248808.307223
},
{
"d": "2026-09-18",
"o": 285.63,
"h": 285.64,
"l": 280.49,
"c": 283.49,
"v": 372801.683276
},
{
"d": "2026-09-21",
"o": 283.67,
"h": 290.51,
"l": 282.45,
"c": 290.07,
"v": 237475.051914
},
{
"d": "2026-09-22",
"o": 291,
"h": 300.48,
"l": 289,
"c": 298.5,
"v": 308765.56414
},
{
"d": "2026-09-23",
"o": 300.44,
"h": 302.44,
"l": 296.08,
"c": 298.41,
"v": 242197.891795
},
{
"d": "2026-09-24",
"o": 296.95,
"h": 303.41,
"l": 296.37,
"c": 299.04,
"v": 210275.656726
},
{
"d": "2026-09-25",
"o": 303.17,
"h": 305.345,
"l": 293.9,
"c": 301.52,
"v": 305796.700606
},
{
"d": "2026-09-28",
"o": 299.78,
"h": 314.94,
"l": 299.7,
"c": 314.1,
"v": 241742.215941
},
{
"d": "2026-09-29",
"o": 313.63,
"h": 317.1,
"l": 304.355,
"c": 310.36,
"v": 430961.61405
},
{
"d": "2026-09-30",
"o": 310.52,
"h": 310.52,
"l": 306.98,
"c": 306.98,
"v": 2307.577431
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 0.49,
"etf_rvol": 1.17,
"rs_5d": 3.48,
"leading": true
}
Data:
{
"estimates": [
{
"symbol": "LGND",
"date": "2030-12-31",
"revenueLow": 622519993,
"revenueHigh": 718016855,
"revenueAvg": 670411667,
"ebitdaLow": 506552582,
"ebitdaHigh": 597886633,
"ebitdaAvg": 552356657,
"ebitLow": 450219881,
"ebitHigh": 541553932,
"ebitAvg": 496023956,
"netIncomeLow": 353459600,
"netIncomeHigh": 425613500,
"netIncomeAvg": 389644819,
"sgaExpenseLow": 220147071,
"sgaExpenseHigh": 253918443,
"sgaExpenseAvg": 237083413,
"epsAvg": 19.2,
"epsHigh": 20.97238,
"epsLow": 17.41695,
"numAnalystsRevenue": 5,
"numAnalystsEps": 1
},
{
"symbol": "LGND",
"date": "2029-12-31",
"revenueLow": 514119766,
"revenueHigh": 592987633,
"revenueAvg": 553672000,
"ebitdaLow": 434067585,
"ebitdaHigh": 512224921,
"ebitdaAvg": 473263522,
"ebitLow": 385670572,
"ebitHigh": 463827908,
"ebitAvg": 424866509,
"netIncomeLow": 302465646,
"netIncomeHigh": 364209941,
"netIncomeAvg": 333430436,
"sgaExpenseLow": 181812571,
"sgaExpenseHigh": 209703290,
"sgaExpenseAvg": 195799766,
"epsAvg": 16.43,
"epsHigh": 17.94668,
"epsLow": 14.90419,
"numAnalystsRevenue": 3,
"numAnalystsEps": 1
},
{
"symbol": "LGND",
"date": "2028-12-31",
"revenueLow": 402164573,
"revenueHigh": 504516619,
"revenueAvg": 458139422,
"ebitdaLow": 400829804,
"ebitdaHigh": 438604904,
"ebitdaAvg": 419717354,
"ebitLow": 358518227,
"ebitHigh": 396293327,
"ebitAvg": 377405777,
"netIncomeLow": 281015293,
"netIncomeHigh": 310857622,
"netIncomeAvg": 295936457.5,
"sgaExpenseLow": 142220898,
"sgaExpenseHigh": 178416528,
"sgaExpenseAvg": 162015763,
"epsAvg": 14.57974,
"epsHigh": 15.31771,
"epsLow": 13.84721,
"numAnalystsRevenue": 7,
"numAnalystsEps": 5
},
{
"symbol": "LGND",
"date": "2027-12-31",
"revenueLow": 353970651,
"revenueHigh": 411018172,
"revenueAvg": 385279798,
"ebitdaLow": 341976334,
"ebitdaHigh": 366852156,
"ebitdaAvg": 354414245,
"ebitLow": 304133900,
"ebitHigh": 329009722,
"ebitAvg": 316571811,
"netIncomeLow": 238051675,
"netIncomeHigh": 257703574,
"netIncomeAvg": 247877624.5,
"sgaExpenseLow": 125177669,
"sgaExpenseHigh": 145351872,
"sgaExpenseAvg": 136249791,
"epsAvg": 12.10951,
"epsHigh": 12.69851,
"epsLow": 11.73015,
"numAnalystsRevenue": 8,
"numAnalystsEps": 7
}
],
"price_target": {
"symbol": "LGND",
"targetHigh": 358,
"targetLow": 326,
"targetConsensus": 339.43,
"targetMedian": 340
},
"ratings": {
"symbol": "LGND",
"rating": "B",
"overallScore": 3,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "LGND",
"date": "2026-09-24",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-09-23",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-08-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-08-06",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-08-03",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-07-15",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-07-09",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-07-08",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-05-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-04-30",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-04-28",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-04-15",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-04-14",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-03-24",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-02-27",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2026-02-24",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-12-10",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-12-10",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-11-10",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-11-07",
"gradingCompany": "Benchmark",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-11-07",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-11-06",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "LGND",
"date": "2025-11-03",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million",
"url": "https://www.globenewswire.com/news-release/2026/09/24/3368190/0/en/ligand-and-avencell-therapeutics-enter-financing-agreement-to-advance-pipeline-of-next-generation-car-t-therapies-for-up-to-47-million.html",
"source": "GlobeNewsWire",
"date": "2026-09-24 07:00:00",
"summary": "JUPITER, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it has entered into a financing agreement with AvenCell Therapeutics, Inc., a clinical-stage cell therapy company developing controllable, allogeneic CAR-T th",
"image": "https://images.financialmodelingprep.com/news/ligand-and-avencell-therapeutics-enter-financing-agreement-to-advance-20260924.jpg"
},
{
"title": "Sydnexis Announces Royalty Agreement with Ligand for Ryjunea\u00ae",
"url": "https://www.businesswire.com/news/home/20260922540496/en/Sydnexis-Announces-Royalty-Agreement-with-Ligand-for-Ryjunea%C2%AE/",
"source": "Business Wire",
"date": "2026-09-22 09:02:00",
"summary": "DEL MAR, Calif.--(BUSINESS WIRE)--Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced an agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) to sell its ",
"image": "https://images.financialmodelingprep.com/news/sydnexis-announces-royalty-agreement-with-ligand-for-ryjunea-20260922.jpg"
},
{
"title": "Primrose Bio\u00ae Raises Significant Growth Capital Investment Led by Signet Healthcare Partners",
"url": "https://www.prnewswire.com/news-releases/primrose-bio-raises-significant-growth-capital-investment-led-by-signet-healthcare-partners-302886141.html",
"source": "PRNewsWire",
"date": "2026-09-22 09:00:00",
"summary": "SAN DIEGO, Sept. 22, 2026 /PRNewswire/ -- Primrose Bio, Inc. (\"Primrose\"), a provider of production solutions for next-generation biologics, today announced the closing of a financing round led by new investor Signet Healthcare Partners (\"Signet\"), with significant participation ",
"image": "https://images.financialmodelingprep.com/news/primrose-bio-raises-significant-growth-capital-investment-led-by-20260922.jpg"
},
{
"title": "Ligand Acquires Royalty and Milestone Interest in Santen's\u00a0Ryjunea\u00ae from Sydnexis for $23 Million",
"url": "https://www.globenewswire.com/news-release/2026/09/22/3366139/0/en/ligand-acquires-royalty-and-milestone-interest-in-santen-s-ryjunea-from-sydnexis-for-23-million.html",
"source": "GlobeNewsWire",
"date": "2026-09-22 07:00:00",
"summary": "Ryjunea is the first and only pharmacologic treatment approved by the European Commission and UK MHRA to slow myopia progression in pediatric patients Ligand will receive a tiered low-double-digit to high-teens royalty on Ryjunea net sales in Europe, the Middle East, and Africa J",
"image": "https://images.financialmodelingprep.com/news/ligand-acquires-royalty-and-milestone-interest-in-santensryjunea-from-20260922.jpg"
},
{
"title": "Ligand Pharmaceuticals: Owning It Gives You A Stake Across Biotech",
"url": "https://seekingalpha.com/article/4947806-ligand-pharmaceuticals-owning-it-gives-you-a-stake-across-biotech",
"source": "Seeking Alpha",
"date": "2026-09-18 08:06:16",
"summary": "Ligand Pharmaceuticals (LGND) is reassessed after a ~10% loss since its last 'Buy' rating. The article focuses on LGND's future prospects, emphasizing its key royalty producing assets. LGND is highlighted as a reliable midcap pharma with a high-growth business model.",
"image": "https://images.financialmodelingprep.com/news/ligand-pharmaceuticals-owning-it-gives-you-a-stake-across-20260918.jpg"
},
{
"title": "Reviewing Omeros (NASDAQ:OMER) & Ligand Pharmaceuticals (NASDAQ:LGND)",
"url": "https://www.defenseworld.net/2026/09/15/reviewing-omeros-nasdaqomer-ligand-pharmaceuticals-nasdaqlgnd.html",
"source": "Defense World",
"date": "2026-09-15 03:59:16",
"summary": "Omeros (NASDAQ: OMER - Get Free Report) and Ligand Pharmaceuticals (NASDAQ: LGND - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, inst",
"image": "https://images.financialmodelingprep.com/news/reviewing-omeros-nasdaqomer-ligand-pharmaceuticals-nasdaqlgnd-20260915.jpg"
},
{
"title": "Ligand to Participate in September Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/08/26/3351186/0/en/ligand-to-participate-in-september-investor-conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-26T11:00:00Z",
"summary": "Ligand Pharmaceuticals announced that its senior management team will participate in three upcoming investor conferences in September 2026: Wells Fargo Healthcare Conference (September 8), Citi 2026 Biopharma Back to School Conference (September 10), and H.C. Wainwright 28th Annu",
"image": "https://ml.globenewswire.com/Resource/Download/1fe91aa2-494e-4b30-89e8-cad771bbaabf"
},
{
"title": "Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital",
"url": "https://www.marketbeat.com/instant-alerts/event-ligand-pharmaceuticals-highlights-xoma-fueled-royalty-growth-700m-in-deployable-capital-2026-08-26/",
"source": "MarketBeat",
"date": "2026-08-26 13:02:51",
"summary": "Ligand Pharmaceuticals NASDAQ: LGND outlined its royalty-focused growth strategy, recent XOMA acquisition and portfolio catalysts during a company presentation, highlighting a larger commercial-stage asset base and planned investment capacity.",
"image": "https://images.financialmodelingprep.com/news/ligand-pharmaceuticals-highlights-xomafueled-royalty-growth-700m-in-deployable-20260826.jpg"
},
{
"title": "Handelsbanken Fonder AB Raises Stake in Ligand Pharmaceuticals Incorporated $LGND",
"url": "https://www.defenseworld.net/2026/08/16/handelsbanken-fonder-ab-raises-stake-in-ligand-pharmaceuticals-incorporated-lgnd.html",
"source": "Defense World",
"date": "2026-08-16 04:49:02",
"summary": "Handelsbanken Fonder AB boosted its stake in Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) by 22.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,358 shares of the biotechnology",
"image": "https://images.financialmodelingprep.com/news/handelsbanken-fonder-ab-raises-stake-in-ligand-pharmaceuticals-incorporated-20260816.jpg"
},
{
"title": "Ligand Pharmaceuticals Q2 Earnings Call Highlights",
"url": "https://www.marketbeat.com/instant-alerts/ligand-pharmaceuticals-q2-earnings-call-highlights-2026-08-06/",
"source": "MarketBeat",
"date": "2026-08-06 17:05:29",
"summary": "Ligand Pharmaceuticals NASDAQ: LGND reported second-quarter 2026 results marked by higher royalty revenue and adjusted earnings, while highlighting the post-quarter close of its XOMA Royalty acquisition and a $700 million zero-coupon convertible-note offering.",
"image": "https://images.financialmodelingprep.com/news/ligand-pharmaceuticals-q2-earnings-call-highlights-20260806.jpg"
},
{
"title": "Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4932313-ligand-pharmaceuticals-incorporated-lgnd-q2-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-08-06 15:14:26",
"summary": "Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/ligand-pharmaceuticals-incorporated-lgnd-q2-2026-earnings-call-transcript-20260806.jpg"
},
{
"title": "Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Arrowstreet Capital Limited Partnership",
"url": "https://www.defenseworld.net/2026/08/05/ligand-pharmaceuticals-incorporated-lgnd-shares-sold-by-arrowstreet-capital-limited-partnership.html",
"source": "Defense World",
"date": "2026-08-05 03:07:23",
"summary": "Arrowstreet Capital Limited Partnership reduced its position in Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) by 27.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,564 sh",
"image": "https://images.financialmodelingprep.com/news/ligand-pharmaceuticals-incorporated-lgnd-shares-sold-by-arrowstreet-capital-limited-20260805.jpg"
},
{
"title": "Ashford Capital Management Inc. Has $41.44 Million Holdings in Ligand Pharmaceuticals Incorporated $LGND",
"url": "https://www.defenseworld.net/2026/07/28/ashford-capital-management-inc-has-41-44-million-holdings-in-ligand-pharmaceuticals-incorporated-lgnd.html",
"source": "Defense World",
"date": "2026-07-28 03:47:31",
"summary": "Ashford Capital Management Inc. reduced its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) by 2.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 207,565 shares of the biotechnology c",
"image": "https://images.financialmodelingprep.com/news/ashford-capital-management-inc-has-4144-million-holdings-in-20260728.jpg"
},
{
"title": "Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026",
"url": "https://www.globenewswire.com/news-release/2026/07/23/3332001/0/en/ligand-to-report-second-quarter-2026-financial-results-on-august-6-2026.html",
"source": "GlobeNewsWire",
"date": "2026-07-23 07:00:00",
"summary": "JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026.",
"image": "https://images.financialmodelingprep.com/news/ligand-to-report-second-quarter-2026-financial-results-on-20260723.jpg"
},
{
"title": "Here Are Tuesday\u2019s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More",
"url": "https://247wallst.com/investing/2026/07/21/here-are-tuesdays-top-wall-street-analyst-research-calls-adobe-datadog-five-below-fortinet-gilead-sciences-goldman-sachs-microsoft-salesforce-and-more/",
"source": "247 Wallst",
"date": "2026-07-21 07:41:44",
"summary": "Wall Street analysts are making bold moves on Tuesday, shaking up ratings for some of the biggest names in tech, biotech, and retail in ways that could catch investors off guard. Find out which stocks got slashed and which ones earned surprise upgrades.",
"image": "https://images.financialmodelingprep.com/news/here-are-tuesdays-top-wall-street-analyst-research-calls-20260721.jpg"
},
{
"title": "3 Overlooked Stocks Positioned for the Next Market Rotation",
"url": "https://www.investing.com/analysis/3-overlooked-stocks-positioned-for-the-next-market-rotation-200683831",
"source": "Investing.com",
"date": "2026-07-13T16:40:00Z",
"summary": "As tech stocks cool and market concentration risks increase, investors should diversify into overlooked sectors. Healthcare, insurance, and regional banking are quietly building momentum. Three recommended stocks are Ligand Pharmaceuticals (royalty-based biotech model with strong",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investingcom_analysis_og.jpg"
},
{
"title": "CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/07/06/crispr-therapeutics-ag-vs-viking-therapeutics-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-07-06T11:35:01Z",
"summary": "The article compares two biotech companies: CRISPR Therapeutics, which has achieved its first gene-editing product approval for sickle cell disease but faces significant losses and customer concentration risks, versus Viking Therapeutics, a clinical-stage company targeting the ob",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5d5d57f05229d5e553cc6e2f816603ec4ca01b17-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date",
"url": "https://www.benzinga.com/pressreleases/26/06/g53179293/xoma-royalty-corporation-declares-quarterly-preferred-stock-dividend-and-announces-redemption-of-i?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-06-12T20:05:00Z",
"summary": "XOMA Royalty Corporation announced quarterly preferred stock dividends for Series A and Series B preferred shareholders, with Series A receiving $0.53906 per share and Series B receiving $0.52344 per depositary share, payable on July 15, 2026. The company also announced the redem",
"image": "https://cdn.benzinga.com/files/imagecache/bz2_opengraph_meta_image_400x300/sites/all/themes/bz2/images/bz-icon.png"
},
{
"title": "Ligand Announces 2026 Investor Day in New York City",
"url": "https://www.globenewswire.com/news-release/2026/06/10/3309572/0/en/Ligand-Announces-2026-Investor-Day-in-New-York-City.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-10T11:00:00Z",
"summary": "Ligand Pharmaceuticals announced it will host an Investor Day in New York City on December 8, 2026, featuring presentations from senior management on the company's strategy, investment activity, royalty portfolio, and long-term financial outlook. A live webcast will be available ",
"image": "https://ml.globenewswire.com/Resource/Download/1fe91aa2-494e-4b30-89e8-cad771bbaabf"
},
{
"title": "A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million",
"url": "https://www.fool.com/coverage/filings/2026/06/07/a-ligand-pharmaceuticals-lgnd-insider-sold-5-000-shares-for-usd1-1-million/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-06-07T12:28:38Z",
"summary": "Andrew Reardon, CLO & Secretary at Ligand Pharmaceuticals, sold 5,000 shares worth approximately $1.14 million on June 1, 2026, through the exercise and immediate disposition of stock options. Post-transaction, Reardon retains 41,382 shares and 39,444 employee stock options. The ",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2Fd227e0f40b399dc519a5bed98ee8a4568fc6efb8-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Villere St Denis Liquidates $18 Million Euronet Worldwide Stake, According to Recent SEC Filing",
"url": "https://www.fool.com/coverage/filings/2026/05/04/villere-st-denis-liquidates-usd18-million-euronet-worldwide-stake-according-to-recent-sec-filing/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-05-04T17:25:29Z",
"summary": "Investment fund Villere St Denis J & Co LLC completely exited its position in Euronet Worldwide, selling 244,878 shares worth approximately $17.53 million in Q1 2026. The liquidation represents a full exit from a position that previously comprised 1.9% of the fund's assets under ",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm",
"url": "https://www.globenewswire.com/news-release/2026/04/28/3283302/0/en/XOMA-Investors-Have-the-Opportunity-to-Join-Investigation-of-XOMA-Royalty-Corporation-with-the-Schall-Law-Firm.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-28T21:40:00Z",
"summary": "The Schall Law Firm is investigating potential breaches of fiduciary duty by XOMA Royalty Corporation's board and management regarding the company's $739 million acquisition by Ligand Pharmaceuticals. Shareholders are invited to participate in the investigation.",
"image": "https://ml.globenewswire.com/Resource/Download/60f84371-8ef5-454a-ab60-63e56a837741"
},
{
"title": "Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million",
"url": "https://www.benzinga.com/m-a/26/04/52072759/ligand-bets-on-royalty-growth-with-xoma-buyout-worth-over-700-million?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-04-27T17:18:03Z",
"summary": "Ligand Pharmaceuticals announced the acquisition of XOMA Royalty Corporation for $739 million ($39.00 per share in cash). The deal is expected to be immediately accretive to adjusted EPS and increases Ligand's 2026 guidance to $8.50-$9.50 per share, with an additional $1.50 per s",
"image": "https://cdn.benzinga.com/files/images/story/2026/04/27/MA.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of XOMA Royalty Corporation (NASDAQ:\u00a0XOMA)",
"url": "https://www.globenewswire.com/news-release/2026/04/27/3281827/0/en/HAREHOLDER-ALERT-The-M-A-Class-Action-Firm-Announces-An-Investigation-of-XOMA-Royalty-Corporation-NASDAQ-XOMA.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-27T14:58:00Z",
"summary": "Monteverde & Associates PC announced investigations into multiple companies involved in M&A transactions, including XOMA Royalty Corporation's proposed sale to Ligand Pharmaceuticals at $39.00 per share in cash. The firm is examining whether the deal terms are fair to shareholder",
"image": "https://ml.globenewswire.com/Resource/Download/24626dc5-f31d-44f3-bc2e-52e339e1a9d1"
},
{
"title": "Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator",
"url": "https://www.benzinga.com/pressreleases/26/04/g52057111/ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligands-positi?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-04-27T11:00:00Z",
"summary": "Ligand Pharmaceuticals announced it will acquire XOMA Royalty Corporation for $39.00 per share in cash, totaling approximately $739 million. The acquisition expands Ligand's royalty portfolio to over 200 assets and adds seven commercial products. Ligand raised its 2026 adjusted E",
"image": "https://cdn.benzinga.com/files/imagecache/bz2_opengraph_meta_image_400x300/sites/all/themes/bz2/images/bz-icon.png"
}
]
Data:
[
{
"symbol": "LGND",
"date": "2026-11-05",
"epsActual": null,
"epsEstimated": 2.26,
"revenueActual": null,
"revenueEstimated": 77948550,
"lastUpdated": "2026-09-30"
},
{
"symbol": "LGND",
"date": "2026-08-06",
"epsActual": 2.37,
"epsEstimated": 2.01,
"revenueActual": 63693000,
"revenueEstimated": 61300380,
"lastUpdated": "2026-09-30"
},
{
"symbol": "LGND",
"date": "2026-05-14",
"epsActual": 1.63,
"epsEstimated": 1.84,
"revenueActual": 51722000,
"revenueEstimated": 59099170,
"lastUpdated": "2026-08-17"
},
{
"symbol": "LGND",
"date": "2026-02-26",
"epsActual": 2.02,
"epsEstimated": 1.46,
"revenueActual": 59666000,
"revenueEstimated": 55588910,
"lastUpdated": "2026-08-17"
},
{
"symbol": "LGND",
"date": "2025-11-06",
"epsActual": 3.09,
"epsEstimated": 1.97,
"revenueActual": 115461000,
"revenueEstimated": 58743860,
"lastUpdated": "2026-08-17"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "LGND",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "LGND",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 5293,
"price": 303.59
},
{
"file_period": "202607a",
"settlement_date": "20260713",
"quantity_fails": 1,
"price": 316.24
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 18,
"price": 296.29
},
{
"file_period": "202608a",
"settlement_date": "20260814",
"quantity_fails": 6144,
"price": 288.82
},
{
"file_period": "202608b",
"settlement_date": "20260831",
"quantity_fails": 1681,
"price": 280.49
},
{
"file_period": "202609a",
"settlement_date": "20260911",
"quantity_fails": 2018,
"price": 289.25
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "LGND",
"filingDate": "2026-09-24",
"transactionDate": "2026-09-22",
"reportingCik": "0001994049",
"companyCik": "0000886163",
"transactionType": "F-InKind",
"securitiesOwned": 3782,
"reportingName": "Zimmermann Martine",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 115,
"price": 298.5,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000142/0002001011-26-000142-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-09-14",
"transactionDate": "2026-09-10",
"reportingCik": "0001994049",
"companyCik": "0000886163",
"transactionType": "S-Sale",
"securitiesOwned": 3897,
"reportingName": "Zimmermann Martine",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1200,
"price": 285,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000140/0002001011-26-000140-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-09-08",
"transactionDate": "2026-09-03",
"reportingCik": "0001950232",
"companyCik": "0000886163",
"transactionType": "S-Sale",
"securitiesOwned": 41214,
"reportingName": "Reardon Andrew",
"typeOfOwner": "officer: CLO & Secretary",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 300,
"price": 283.9854,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000137/0002001011-26-000137-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-09-08",
"transactionDate": "2026-09-03",
"reportingCik": "0001950232",
"companyCik": "0000886163",
"transactionType": "S-Sale",
"securitiesOwned": 39414,
"reportingName": "Reardon Andrew",
"typeOfOwner": "officer: CLO & Secretary",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1800,
"price": 285.1671,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000137/0002001011-26-000137-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-09-08",
"transactionDate": "2026-09-03",
"reportingCik": "0001950232",
"companyCik": "0000886163",
"transactionType": "S-Sale",
"securitiesOwned": 37299,
"reportingName": "Reardon Andrew",
"typeOfOwner": "officer: CLO & Secretary",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2115,
"price": 286.3589,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000137/0002001011-26-000137-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-09-08",
"transactionDate": "2026-09-03",
"reportingCik": "0001950232",
"companyCik": "0000886163",
"transactionType": "S-Sale",
"securitiesOwned": 36914,
"reportingName": "Reardon Andrew",
"typeOfOwner": "officer: CLO & Secretary",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 385,
"price": 287.5253,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000137/0002001011-26-000137-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-09-08",
"transactionDate": "2026-09-03",
"reportingCik": "0001950232",
"companyCik": "0000886163",
"transactionType": "S-Sale",
"securitiesOwned": 36514,
"reportingName": "Reardon Andrew",
"typeOfOwner": "officer: CLO & Secretary",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 400,
"price": 288.9792,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000137/0002001011-26-000137-index.htm"
},
{
"symbol": "LGND",
"filingDate": "2026-08-14",
"transactionDate": "2026-08-12",
"reportingCik": "0001905248",
"companyCik": "0000886163",
"transactionType": "M-Exempt",
"securitiesOwned": 59337,
"reportingName": "Espinoza Octavio",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3348,
"price": 68.74,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/886163/000200101126000115/0002001011-26-000115-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "LGND",
"senateID": "C001123",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-29",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Ligand Pharmaceuticals Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034713.pdf"
},
{
"symbol": "LGND",
"senateID": "C001123",
"disclosureDate": "2026-04-08",
"transactionDate": "2026-03-03",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Ligand Pharmaceuticals Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034285.pdf"
},
{
"symbol": "LGND",
"senateID": "C001123",
"disclosureDate": "2026-02-13",
"transactionDate": "2026-01-15",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Ligand Pharmaceuticals Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20033983.pdf"
},
{
"symbol": "LGND",
"senateID": "C001123",
"disclosureDate": "2026-02-13",
"transactionDate": "2026-01-05",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Ligand Pharmaceuticals Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20033983.pdf"
},
{
"symbol": "LGND",
"senateID": "C001101",
"disclosureDate": "2020-12-03",
"transactionDate": "2020-10-22",
"firstName": "Katherine M.",
"lastName": "Clark",
"office": "Katherine M. Clark",
"district": "MA05",
"owner": "Spouse",
"assetDescription": "Ligand Pharmaceuticals Incorporated",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017790.pdf"
},
{
"symbol": "LGND",
"senateID": "C001101",
"disclosureDate": "2020-05-29",
"transactionDate": "2020-04-03",
"firstName": "Katherine M.",
"lastName": "Clark",
"office": "Katherine M. Clark",
"district": "MA05",
"owner": "Spouse",
"assetDescription": "Ligand Pharmaceuticals Incorporated",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016678.pdf"
}
],
"dark_pool": [
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:00.668000Z",
"size": 5534.0,
"price": 310.36,
"premium": 1717532.24,
"volume": 5534.0,
"trade_code": "6"
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:00.665000Z",
"size": 3292.0,
"price": 310.36,
"premium": 1021705.12,
"volume": 3292.0,
"trade_code": "6"
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:00.668000Z",
"size": 2944.0,
"price": 310.36,
"premium": 913699.8400000001,
"volume": 2944.0,
"trade_code": "6"
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:00.665000Z",
"size": 2494.0,
"price": 310.36,
"premium": 774037.8400000001,
"volume": 2494.0,
"trade_code": "6"
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:05.917000Z",
"size": 2011.0,
"price": 310.36,
"premium": 624133.9600000001,
"volume": 2011.0,
"trade_code": " "
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:05.915000Z",
"size": 1689.0,
"price": 310.36,
"premium": 524198.04000000004,
"volume": 1689.0,
"trade_code": " "
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:00.668000Z",
"size": 1586.0,
"price": 310.36,
"premium": 492230.96,
"volume": 1586.0,
"trade_code": "6"
},
{
"ticker": "LGND",
"executed_at": "2026-09-29T20:00:00.670000Z",
"size": 961.0,
"price": 310.36,
"premium": 298255.96,
"volume": 961.0,
"trade_code": "6"
}
],
"ats": {
"symbol": "LGND",
"date": "20260929",
"ats_volume": 0,
"total_volume": 243760,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260929",
"ats_ratio": 0.0
},
{
"date": "20260928",
"ats_ratio": 0.0
},
{
"date": "20260925",
"ats_ratio": 0.0
},
{
"date": "20260924",
"ats_ratio": 0.0
},
{
"date": "20260923",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "LGND",
"days": [
{
"date": "2026-09-30",
"close": 306.98,
"vwap": 309.36,
"volume": 2307,
"vwap_discount_pct": 0.77
},
{
"date": "2026-09-29",
"close": 310.36,
"vwap": 308.8,
"volume": 430961,
"vwap_discount_pct": -0.5
},
{
"date": "2026-09-28",
"close": 314.1,
"vwap": 310.33,
"volume": 241742,
"vwap_discount_pct": -1.2
},
{
"date": "2026-09-25",
"close": 301.52,
"vwap": 301.42,
"volume": 305796,
"vwap_discount_pct": -0.03
},
{
"date": "2026-09-24",
"close": 299.04,
"vwap": 299.37,
"volume": 210275,
"vwap_discount_pct": 0.11
}
],
"avg_vwap_discount_pct": -0.17,
"signal": "Distribution"
},
"options_flow": [
{
"volume": 2,
"expiry": "2027-12-17",
"size": 2,
"delta": "-0.4468815731637812",
"executed_at": "2026-09-29T19:23:58.029000Z",
"price": "73.50",
"nbbo_ask": "73.50",
"strike": "350",
"sector": "Healthcare",
"implied_volatility": "0.456034222002789",
"nbbo_bid": "69.00",
"open_interest": 0,
"option_chain_id": "LGND271217P00350000",
"underlying_price": "310.68",
"premium": "14700.00",
"option_type": "put",
"underlying_symbol": "LGND"
},
{
"volume": 4,
"expiry": "2027-12-17",
"size": 2,
"delta": "-0.4471181089711822",
"executed_at": "2026-09-29T19:23:58.031000Z",
"price": "73.40",
"nbbo_ask": "73.40",
"strike": "350",
"sector": "Healthcare",
"implied_volatility": "0.455296170154249",
"nbbo_bid": "73.30",
"open_interest": 0,
"option_chain_id": "LGND271217P00350000",
"underlying_price": "310.68",
"premium": "14680.00",
"option_type": "put",
"underlying_symbol": "LGND"
},
{
"volume": 1,
"expiry": "2026-10-16",
"size": 1,
"delta": "0.974021082430739",
"executed_at": "2026-09-29T13:44:41.103000Z",
"price": "129.70",
"nbbo_ask": "133.50",
"strike": "185",
"sector": "Healthcare",
"implied_volatility": "1.397701865569481",
"nbbo_bid": "129.70",
"open_interest": 1,
"option_chain_id": "LGND261016C00185000",
"underlying_price": "317.1",
"premium": "12970.00",
"option_type": "call",
"underlying_symbol": "LGND"
}
],
"net_premium": {
"ticker": "LGND",
"net_call_premium": "-40495.00",
"net_put_premium": "28120.00",
"call_premium": "52065.00",
"put_premium": "30640.00",
"bullish_premium": "5215.00",
"bearish_premium": "73830.00",
"put_call_ratio": "0.1428571428571428571428571429",
"iv_rank": "26.4975",
"implied_move_perc": "0.077",
"gex_ratio": "0.56360808681422419870",
"gex_net_change": "25.5279",
"gex_call": "244.5638",
"gex_put": "-136.2291",
"gex_net": 108.3347,
"gex_call_delta": "26969.1813",
"gex_put_delta": "-9725.7233",
"gex_date": "2026-09-30"
},
"hot_chains": [
{
"open_interest": 18,
"volume": 5,
"last_price": "12.90",
"option_symbol": "LGND261016C00300000",
"ask_volume": 0,
"bid_volume": 5,
"nbbo_bid": "14.30",
"nbbo_ask": "17.90",
"avg_price": "12.9000"
},
{
"open_interest": 1,
"volume": 5,
"last_price": "0.80",
"option_symbol": "LGND261016C00350000",
"ask_volume": 1,
"bid_volume": 4,
"nbbo_bid": "0.60",
"nbbo_ask": "2.10",
"avg_price": "0.8000000000000000000000000000"
},
{
"open_interest": 0,
"volume": 4,
"last_price": "73.40",
"option_symbol": "LGND271217P00350000",
"ask_volume": 4,
"bid_volume": 0,
"nbbo_bid": "69.50",
"nbbo_ask": "73.00",
"avg_price": "73.4500"
},
{
"open_interest": 20,
"volume": 4,
"last_price": "26.70",
"option_symbol": "LGND270219C00320000",
"ask_volume": 0,
"bid_volume": 4,
"nbbo_bid": "26.50",
"nbbo_ask": "29.90",
"avg_price": "27.800000000000000000000000000"
},
{
"open_interest": 3,
"volume": 3,
"last_price": "8.70",
"option_symbol": "LGND270219C00390000",
"ask_volume": 0,
"bid_volume": 3,
"nbbo_bid": "7.70",
"nbbo_ask": "10.40",
"avg_price": "8.933333333333333333333333333"
},
{
"open_interest": 2,
"volume": 3,
"last_price": "1.65",
"option_symbol": "LGND261218C00430000",
"ask_volume": 3,
"bid_volume": 0,
"nbbo_bid": "0.70",
"nbbo_ask": "2.25",
"avg_price": "1.6333333333333333333333333333"
},
{
"open_interest": 2,
"volume": 2,
"last_price": "31.20",
"option_symbol": "LGND270219C00310000",
"ask_volume": 0,
"bid_volume": 2,
"nbbo_bid": "31.00",
"nbbo_ask": "34.50",
"avg_price": "31.1000"
},
{
"open_interest": 4,
"volume": 2,
"last_price": "7.50",
"option_symbol": "LGND261016C00320000",
"ask_volume": 0,
"bid_volume": 0,
"nbbo_bid": "3.70",
"nbbo_ask": "7.60",
"avg_price": "7.50"
}
],
"gamma_profile": {
"ticker": "LGND",
"spot": null,
"date": "2026-09-30",
"flip_point": 316.62,
"net_gex": 108.33,
"call_walls": [
{
"strike": 300.0,
"gex": 36.84
},
{
"strike": 370.0,
"gex": 31.57
},
{
"strike": 320.0,
"gex": 28.27
}
],
"put_walls": [
{
"strike": 300.0,
"gex": -43.88
},
{
"strike": 260.0,
"gex": -23.29
},
{
"strike": 330.0,
"gex": -11.62
}
],
"by_strike": [
{
"strike": 110.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 115.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 120.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 125.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 130.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 135.0,
"call_gex": 0.0,
"put_gex": -0.0,
"net_gex": 0.0
},
{
"strike": 140.0,
"call_gex": 0.28,
"put_gex": -0.0,
"net_gex": 0.28
},
{
"strike": 145.0,
"call_gex": 0.0,
"put_gex": -0.0,
"net_gex": -0.0
},
{
"strike": 150.0,
"call_gex": 0.0,
"put_gex": -0.0,
"net_gex": -0.0
},
{
"strike": 155.0,
"call_gex": 0.0,
"put_gex": -0.0,
"net_gex": -0.0
},
{
"strike": 160.0,
"call_gex": 0.0,
"put_gex": -0.12,
"net_gex": -0.12
},
{
"strike": 165.0,
"call_gex": 0.0,
"put_gex": -0.25,
"net_gex": -0.24
},
{
"strike": 170.0,
"call_gex": 0.0,
"put_gex": -0.34,
"net_gex": -0.34
},
{
"strike": 175.0,
"call_gex": 0.02,
"put_gex": -0.22,
"net_gex": -0.2
},
{
"strike": 180.0,
"call_gex": 0.19,
"put_gex": -0.41,
"net_gex": -0.22
},
{
"strike": 185.0,
"call_gex": 0.1,
"put_gex": -0.56,
"net_gex": -0.46
},
{
"strike": 190.0,
"call_gex": 0.1,
"put_gex": -0.39,
"net_gex": -0.3
},
{
"strike": 195.0,
"call_gex": 0.19,
"put_gex": -0.06,
"net_gex": 0.13
},
{
"strike": 200.0,
"call_gex": 0.33,
"put_gex": -0.53,
"net_gex": -0.21
},
{
"strike": 210.0,
"call_gex": 0.08,
"put_gex": -0.54,
"net_gex": -0.46
},
{
"strike": 220.0,
"call_gex": 1.26,
"put_gex": -3.47,
"net_gex": -2.21
},
{
"strike": 230.0,
"call_gex": 0.56,
"put_gex": -3.82,
"net_gex": -3.26
},
{
"strike": 240.0,
"call_gex": 1.17,
"put_gex": -2.96,
"net_gex": -1.8
},
{
"strike": 250.0,
"call_gex": 2.86,
"put_gex": -2.42,
"net_gex": 0.43
},
{
"strike": 260.0,
"call_gex": 11.25,
"put_gex": -23.29,
"net_gex": -12.04
}
]
},
"oi_changes": {
"net_call_oi_change": 4,
"net_put_oi_change": 0,
"top": [
{
"strike": null,
"oi_change": 2,
"type": "call"
},
{
"strike": null,
"oi_change": 2,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "put"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": -11.7,
"D": -29.1,
"P": 40.3,
"O": -17.9,
"C": 40.0,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": 21.8,
"T": 91.8,
"RS": 87.8,
"V": -39.0,
"F": -100.0,
"OI": 100.0,
"S": null,
"IV": -52.8,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": 69.4,
"FlowAgreement": 66.7,
"StrikeBreadth": 33.3
},
"drivers": [
"- aggressive flow -100",
"+ open-interest change +100",
"+ trend +92",
"+ relative strength +88",
"- IV behaviour -53"
]
}
}
Data:
{
"vix": 15.67,
"sp500": 7743.41,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.36,
"hy_spread": 2.8,
"treasury": {
"date": "2026-09-28",
"month1": 4.04,
"month2": 4.2,
"month3": 4.28,
"month6": 4.41,
"year1": 4.59,
"year2": 4.92,
"year3": 5.01,
"year5": 5.06,
"year7": 5.15,
"year10": 5.24,
"year20": 5.6,
"year30": 5.56
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.2%",
"actual": null,
"minutes_until": -8
},
{
"title": "Final GDP q/q",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": -8
},
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 2871
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "90K",
"previous": "162K",
"actual": null,
"minutes_until": 2871
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 2871
}
]
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 98,
"pct": 95
},
{
"name": "ORB Breakout",
"count": 96,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 85,
"pct": 83
},
{
"name": "Gap Fill",
"count": 81,
"pct": 79
},
{
"name": "Open Retracement",
"count": 78,
"pct": 76
},
{
"name": "Darvas Box",
"count": 36,
"pct": 35
},
{
"name": "High Vol Open",
"count": 30,
"pct": 29
},
{
"name": "Power Hour",
"count": 23,
"pct": 22
}
]
}